However, both are positive for GFAP and have similar genomic signatures, consisting of identical point mutations in PTEN, RB1, TERT promoter, and TP53. Therefore, these two components most likely arise from a common glioblastoma progenitor cell. Here, RB1 is linked to glioblastoma.